Allergan agreed to acquire Tobira Therapeutics, a biopharmaceutical company that develops therapies for liver diseases, in a deal the companies said potentially is worth roughly $1.7 billion.
from WSJ.com: US Business http://ift.tt/2ddGUCX
via IFTTT
No comments:
Post a Comment